Stock QLGN QUALIGEN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Qualigen Therapeutics, Inc.

Equities

QLGN

US74754R2022

Delayed Nasdaq
Other stock markets
 12:21:48 2024-04-29 pm EDT 		5-day change 1st Jan Change
0.295 USD +1.55% Intraday chart for Qualigen Therapeutics, Inc. -0.10% -46.36%
Apr. 16 Marizyme Enters into Co-Development Agreement with Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft? CI
Apr. 08 Qualigen Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Ritter Pharmaceuticals, Inc. - Shareholder/Analyst Call
Transcript : Ritter Pharmaceuticals, Inc. - Special Call
Transcript : Ritter Pharmaceuticals, Inc. - Special Call
Transcript : Ritter Pharmaceuticals, Inc. - Special Call
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. QLGN Stock
  4. News Qualigen Therapeutics, Inc.
  5. Transcripts